THYROID CANCER, PAPILLARY
Clinical trials for THYROID CANCER, PAPILLARY explained in plain language.
Never miss a new study
Get alerted when new THYROID CANCER, PAPILLARY trials appear
Sign up with your email to follow new studies for THYROID CANCER, PAPILLARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can two drugs reboot radioiodine therapy for tough thyroid cancers?
Disease control CompletedThis early-phase trial tested two drugs, vemurafenib and copanlisib, in 8 people with advanced BRAF-mutant thyroid cancers that had stopped responding to radioiodine therapy. The goal was to see if the combination could make tumors sensitive to radioiodine again and to find the s…
Matched conditions: THYROID CANCER, PAPILLARY
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 14:34 UTC
-
Hidden cancer cells in lymph nodes may force second thyroid surgery in many patients
Knowledge-focused CompletedThis study looked at 314 patients with small, early-stage papillary thyroid cancer who had surgery to remove half of the thyroid. During the operation, doctors checked nearby lymph nodes for hidden cancer spread. If cancer was found, the rest of the thyroid was removed in the sam…
Matched conditions: THYROID CANCER, PAPILLARY
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:45 UTC